Neurovations is focused on new and innovative clinical trials and treatments for chronic pain and neurologic disease. Founded by Eric Grigsby, MD, MBA, long-time leader in pain management, Neurovations enjoys a reputation for excellence decades in the making. Our team has led clinical trials for more than 25 companies in the fields of pain management and minimally invasive spine care, partnering with industry leaders and early-stage companies in medical device (Phase I-IV) and pharmaceutical trials (Phase II-IV).
We partner with our sister company, Neurovations Clinical Research, to offer our patients access to advanced new trial therapies for Chronic Pain.
Current Clinical Trials
Chronic Pain of the Amputated Leg
This study is open to patients with moderate to severe post-amputation pain lasting over six months. The purpose of this clinical trial is to evaluate whether electrical nerve block via the Altius System is a safe and effective treatment for patients with post-amputation pain. The investigational device is currently in the pre-market approval stage. You may qualify to take part in this clinical study if you:
- Have one amputated lower limb
- Have frequent and recurring pain which resulted from amputation
- Are over 21 years of age
Knee Pain Study
If you have osteoarthritis of the knee and have been told you may need a knee replacement, you may qualify for a study that involves a single injection. Please call 707-252-9606 to see if you would qualify.
Patients and referring providers interested in learning more about our current clinical trials can call 707-252-9606.